Special Issue "Neuropathology: From Molecular Mechanisms to Therapeutic Solutions"
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 5206
Interests: neuroinflammation; neurodevelopment; neurogenesis; neurodegenerative diseases
In recent years, there has been a dramatic increase in the number of patients with neurological diseases including neurodegenerative diseases. This has exerted a major societal and financial burden worldwide, and these diseases remain a major cause of disability. Many neurological disorders strike primarily in mid- to late life; their incidence is expected to soar as the population ages. By 2030, as many as one in five Americans will be over the age 65, and more than 12 million Americans will suffer from neurological disorders. Promising studies have been made to understand the molecular mechanisms of disease progression and detailed insights into potential therapeutic solutions. This Special Issue focuses on new and fast-developing knowledge on the disease mechanisms and therapeutic approaches for neurological diseases.
This Special Issue intends to highlight the advances in our understanding of the molecular mechanisms of neurological disorders and potential therapeutic solutions to slow down or prevent the progression of the diseases. With this Special Issue, we hope to provide a comprehensive overview from molecular mechanisms to therapeutic solutions of neurological diseases for the broad readership of the journal.
Dr. Wenqiang Fan
Dr. Xingping Qin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular neuropathology
- pathogenesis of nervous system disorders
- CNS tumors
- multiple sclerosis
- neurodegenerative diseases
- Alzheimer disease